Denali Therapeutics (4DN.F) Q4 2025 Earnings

6NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.77
-0.72
-0.66
-0.61

Details

Expected EPS
-0.6473087592899999
Actual EPS
-0.6406845999999999
Surprise EPS
0.01
Surprise Percent
+1.02%

Description

Denali Therapeutics (4DN.F) has reported earnings of -0.6406845999999999 per share for Q4 2025.

0 Comments

Share your thoughts